Rezultati pretrage - Axel Finckh
- Prikaz rezultata 1 – 20 od 55
- Idi na sljedeću stranicu
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Comparative Efficacy of Novel DMARDs as Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients with Inadequate Response to Conventional DMARDs: A Network... od Felicity Buckley, Axel Finckh, T. Huizinga, F. Dejonckheere, Jeroen P. Jansen
Izdano 2015Revisão -
10
-
11
-
12
-
13
-
14
Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis? Results from the Swiss prospective observational cohort od R Mueller, T. Kaegi, Axel Finckh, Sarah R. Haile, Hendrik Schulze‐Koops, J. von Kempis
Izdano 2013Artigo -
15
-
16
-
17
Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an a... od Axel Finckh, Adrian Ciurea, Laure Brulhart, Burkhard Möller, Ulrich A. Walker, D. Courvoisier, Diego Kyburz, Jean Dudler, Cem Gabay
Izdano 2009Artigo -
18
-
19
-
20
Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis od Matthias Jarlborg, Delphine S. Courvoisier, Céline Lamacchia, Laura Martinez Prat, Michael Mähler, Chelsea Bentow, Axel Finckh, Cem Gabay, Michael J. Nissen
Izdano 2020Artigo
Alati za pretragu:
Povezani predmeti
Medicine
Internal medicine
Rheumatoid arthritis
Disease
Physical therapy
Immunology
Arthritis
Environmental health
Population
Cohort
Rituximab
Antirheumatic Agents
Observational study
Pathology
Rheumatology
Adalimumab
Adverse effect
Lymphoma
Tofacitinib
Alternative medicine
Biology
Computer science
Etanercept
Gastroenterology
Intensive care medicine
Oncology
Surgery
Abatacept
Clinical trial
Confounding